Onxeo S.A. (TopoTarget A/S)

Targovax AS (Oncos)

This biotechnology company develops circular RNA therapeutics and oncolytic virus-based immunotherapies for patients with solid tumours and other difficult-to-treat diseases.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Aprea Therapeutics

This company develops targeted cancer therapies for patients with biomarker-defined tumours and DNA damage response pathway defects.

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

Apim Therapeutics

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses for patients with advanced cancers including ovarian cancer and sarcoma.

Adcendo

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.

Oncko

This company develops multi-drug cancer therapies and clinical platform trials to identify optimal treatment combinations and schedules for pharmaceutical partners and patients.

Noxxon Pharma

This biotechnology firm develops mirror-image oligonucleotide therapeutics to treat aggressive cancers by targeting the tumour microenvironment for patients and pharmaceutical partners.